EDIT: Removed press release
EDIT: Juvenescence put out a press release in error on May 21st, and it has been removed.
- scPharmaceuticals in pricing of public offering of common stock of about $50.0 million
- Gilead and Galapagos announce positive topline results of phase 2B/3 trial of Filgotinib in moderately to severely active ulcerative colitis